|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-8-25
|
|
pubmed:abstractText |
We have previously demonstrated that high-dose chemoradiotherapy followed by resection for patients selected on the basis of mediastinal sterilization was feasible and resulted in excellent outcomes. This study was designed to determine the ability to intensify our prior approach utilizing hyperfractionated radiation and more aggressive consolidative chemotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1552-6259
|
|
pubmed:author |
pubmed-author:BurrowsWhitneyW,
pubmed-author:BuskirkSusanS,
pubmed-author:CooperLindsay BLB,
pubmed-author:DoyleL AustinLA,
pubmed-author:EdelmanMartin JMJ,
pubmed-author:GamlielZivZ,
pubmed-author:HausnerPetrP,
pubmed-author:KennedyNancy LNL,
pubmed-author:KrasnaMark JMJ,
pubmed-author:KwongKing FKF,
pubmed-author:MitraNehaN,
pubmed-author:RileyMichelleM,
pubmed-author:SuntharalingamMohanM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
903-10
|
|
pubmed:meshHeading |
pubmed-meshheading:18721580-Adult,
pubmed-meshheading:18721580-Aged,
pubmed-meshheading:18721580-Antineoplastic Agents,
pubmed-meshheading:18721580-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18721580-Carboplatin,
pubmed-meshheading:18721580-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18721580-Combined Modality Therapy,
pubmed-meshheading:18721580-Dose Fractionation,
pubmed-meshheading:18721580-Drug Administration Schedule,
pubmed-meshheading:18721580-Female,
pubmed-meshheading:18721580-Humans,
pubmed-meshheading:18721580-Lung Neoplasms,
pubmed-meshheading:18721580-Male,
pubmed-meshheading:18721580-Middle Aged,
pubmed-meshheading:18721580-Vinblastine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.
|
|
pubmed:affiliation |
Division of Medical Oncology, University of Maryland School of Medicine and University of Maryland Greenebaum Cancer Center, Baltimore, Maryland 21201, USA. medelman@umm.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
